Finance

Lists
Why is SGMT down 5,45%?
Dive Deeper
SGMT:NASDAQ
Sagimet Biosciences Inc
7,54 $
-5,45%
(-0,43) 1D
7,66 $
+1,52% (+0,11)
Pre-market
Closed: 14 қаз., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SGMT...
Open
7,78 $
High
8,00 $
Low
7,51 $
Mkt. cap
532,17 млн
Avg. vol.
1,37 млн
Volume
3,32 мың
52-wk high
11,45 $
52-wk low
4,50 $
EPS
-1,28 $
Beta
3,46
Shares outstanding
70,34 млн
No. of employees
16
Open
7,78 $
High
8,00 $
Low
7,51 $
Mkt. cap
532,17 млн
Avg. vol.
1,37 млн
Volume
3,32 мың
52-wk high
11,45 $
52-wk low
4,50 $
EPS
-1,28 $
Beta
3,46
Shares outstanding
70,34 млн
No. of employees
16
News stories
From web sources and news partners
About Sagimet Biosciences Inc
CEO-
Employees16
Founded2006
HeadquartersSan Mateo, Калифорния, Америка Құрама Штаттары
Sector-
Websitesagimet.com
Analyst ratings
Based on 12 analysts giving stock ratings to SGMT in the past 3 months
Strong buy
Buy
11
Hold
0
Sell
1
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for SGMT in the last 3 months.
Highest
Current 7,54 $
56,00 $ (+642,21%)
Average
28,46 $ (+277,20%)
Lowest
7,00 $ (-7,22%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
29,00 $
+284,4%
10/05/2026
Seamus Fernandez
Guggenheim
Buy
Reiterated
26,00 $
+244,6%
10/01/2026
Thomas Smith
Leerink Partners
Buy
Reiterated
-
-
10/01/2026
Andrea Newkirk
Goldman Sachs
Sell
Maintained
7,00 $
-7,2%
09/30/2026
Jay Olson
Oppenheimer
Buy
Maintained
38,00 $
+403,6%
10/01/2026
Edward Nash
Canaccord Genuity
Buy
Reiterated
56,00 $
+642,2%
10/01/2026
Yanni Souroutzidis
Cantor Fitzgerald
Buy
Maintained
25,10 $
+232,7%
10/01/2026
Yun Zhong
Wedbush
Buy
Maintained
28,00 $
+271,1%
10/01/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
27,00 $
+257,9%
10/01/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
28,00 $
+271,1%
09/30/2026
Debanjana Chatterjee
JonesTrading
Buy
Reiterated
31,00 $
+310,9%
09/27/2026
Eliana Merle
Barclays
Buy
Upgraded
18,00 $
+138,6%
09/09/2026
Ritu Baral
TD Cowen
Buy
Maintained
21,00 $
+178,3%
05/12/2026
Unknown Analyst
Rodman & Renshaw
Buy
Initiated
28,00 $
+271,1%
03/26/2026
Seema Sheoran
Rodman & Renshaw
Buy
Initiated
28,00 $
+271,1%
03/26/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
9,73 млн
6,73 млн
7,00 млн
11,54 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,60 млн
4,03 млн
4,72 млн
4,28 млн
Operating expense
14,33 млн
10,76 млн
11,71 млн
15,82 млн
Total operating expenses
14,33 млн
10,76 млн
11,71 млн
15,82 млн
Operating income
-14,33 млн
-10,76 млн
-11,71 млн
-15,82 млн
Other non operating income
-
-
-
-
EBT including unusual items
-12,91 млн
-9,57 млн
-10,65 млн
-13,95 млн
EBT excluding unusual items
-12,91 млн
-9,57 млн
-10,65 млн
-13,95 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12,91 млн
-9,57 млн
-10,65 млн
-13,95 млн
Net profit margin
-
-
-
-
Earnings per share
-0,40
-0,29
-0,33
-0,26
Interest and investment income
1,43 млн
1,20 млн
1,06 млн
1,86 млн
Interest expense
-
-
-
-
Net interest expenses
1,43 млн
1,20 млн
1,06 млн
1,86 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары